相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Factors influencing retention of adenovirus within tumours following direct intratumoural injection
M. Bazan-Peregrino et al.
GENE THERAPY (2008)
PRB-E2F1 complexes are resistant to adenovirus E1A-mediated disruption
L. A. Seifried et al.
JOURNAL OF VIROLOGY (2008)
The AP-1 transcription factor regulates breast cancer cell growth via cyclins and E2F factors
Q. Shen et al.
ONCOGENE (2008)
Hypoxia and breast cancer: prognostic and therapeutic implications
K. Lundgren et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2007)
Breast cancer incidence, 1980-2006: Combined roles of menopausal hormone therapy, screening mammography, and estrogen receptor status
Andrew G. Glass et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2007)
Myxoma virus and oncolytic virotherapy: a new biologic weapon in the war against cancer
Marianne M. Stanford et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2007)
Autocrine WNT signaling contributes to breast cancer cell proliferation via the canonical WNT pathway and EGFR transactivation
Thomas Schlange et al.
BREAST CANCER RESEARCH (2007)
A phase I trial of intravenous CG7870, a replication-selective, prostate-specific antigen-targeted oncolytic adenovirus, for the treatment of hormone-refractory, metastatic prostate cancer
Eric J. Small et al.
MOLECULAR THERAPY (2006)
Inactivation of Wnt inhibitory factor-1 (WIF1) expression by epigenetic silencing is a common event in breast cancer
Lingbao Ai et al.
CARCINOGENESIS (2006)
Differentially regulated interferon response determines the outcome of Newcastle disease virus infection in normal and tumor cell lines
Sateesh Krishnamurthy et al.
JOURNAL OF VIROLOGY (2006)
Employment of liver tissue slice analysis to assay hepatotoxicity linked to replicative and nonreplicative adenoviral agents
M. A. Stoff-Khalili et al.
CANCER GENE THERAPY (2006)
Patterns of cancer incidence, mortality, and prevalence across five continents: Defining priorities to reduce cancer disparities in different geographic regions of the world
Farin Kamangar et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Cell cycle control related proteins (p53, p21, and Rb) and transforming growth factor β (TGFβ) in benign and carcinomatous (in situ and infiltrating) human breast:: Implications in malignant transformations
I García-Tuñón et al.
CANCER INVESTIGATION (2006)
Wnt signaling pathway in mammary gland development and carcinogenesis
Gulisa Turashvili et al.
PATHOBIOLOGY (2006)
Recent progress in the battle between oncolytic viruses and tumours
KA Parato et al.
NATURE REVIEWS CANCER (2005)
RAD001 (everolimus) improves the efficacy of replicating adenoviruses that target colon cancer
K Homicsko et al.
CANCER RESEARCH (2005)
Extended plasma circulation time and decreased toxicity of polymer-coated adenovirus
NK Green et al.
GENE THERAPY (2004)
Late viral RNA export, rather than p53 inactivation, determines ONYX-015 tumor selectivity
CC O'Shea et al.
CANCER CELL (2004)
Experimental infections of humans with wild-type adenoviruses and with replication-competent adenovirus vectors: replication, safety, and transmission
DL Lichtenstein et al.
CANCER GENE THERAPY (2004)
Use of replication-conditional adenovirus as a helper system to enhance delivery of P450 prodrug-activation genes for cancer therapy
Y Jounaidi et al.
CANCER RESEARCH (2004)
An autocrine mechanism for constitutive Wnt pathway activation in human cancer cells
A Bafico et al.
CANCER CELL (2004)
The impact of adenovirus infection on the immunocompromised host
T Kojaoghlanian et al.
REVIEWS IN MEDICAL VIROLOGY (2003)
E3 gene manipulations affect oncolytic adenovirus activity in immunocompetent tumor models
YH Wang et al.
NATURE BIOTECHNOLOGY (2003)
Evaluation of E1B gene-attenuated replicating adenoviruses for cancer gene therapy
J Kim et al.
CANCER GENE THERAPY (2002)
New oncolytic adenoviruses with hypoxia- and estrogen receptor-regulated replication
R Hernandez-Alcoceba et al.
HUMAN GENE THERAPY (2002)
YB-1 relocates to the nucleus in adenovirus-infected cells and facilitates viral replication by inducing E2 gene expression through the E2 late promoter
PS Holm et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Adenoviruses with Tcf binding sites in multiple early promoters show enhanced selectivity for tumour cells with constitutive activation of the wnt signalling pathway
C Fuerer et al.
GENE THERAPY (2002)
β-catenin is a downstream effector of Wnt-mediated tumorigenesis in the mammary gland
JS Michaelson et al.
ONCOGENE (2001)
Gene delivery from the E3 region of replicating human adenovirus: evaluation of the E3B region
LK Hawkins et al.
GENE THERAPY (2001)
Clinical research results with dl1520 (Onyx-015), a replication-selective adenovirus for the treatment of cancer: what have we learned?
D Kirn
GENE THERAPY (2001)
An adenovirus E1A mutant that demonstrates potent and selective systemic anti-tumoral efficacy
C Heise et al.
NATURE MEDICINE (2000)
分享论文
